Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sharecare, Inc. Stockholders Should Contact Robbins LLP Regarding the Pending Lead Plaintiff Deadline in the SHCR Securities Class Action By: Robbins LLP via GlobeNewswire May 07, 2024 at 15:28 PM EDT SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Sharecare, Inc. (NASDAQ: SHCR) securities between May 10, 2023 and March 28, 2024. Sharecare developed an interactive health and wellness platform to help people, patients, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating the Allegations that Sharecare, Inc. (SHCR) had Material Weaknesses in Internal Control Over Financial Reporting According to the complaint, during the class period defendants failed to disclose to investors that Sharecare lacked adequate internal controls. On March 29, 2024, Sharecare filed with the SEC its Annual Report on Form 10-K for the year ended December 31, 2023, sharing that its Chief Executive Officer and Chief Financial Officer determined that the Company's disclosure controls and procedures were ineffective as of December 31, 2023, due to material weaknesses in the Company's internal control over financial reporting. On this news, the price of Sharecare stock fell by $0.2171, or 28.28%, to close at $0.5504 on April 1, 2024, on unusually heavy trading volume, damaging investors. What Now: You may be eligible to participate in the class action against Sharecare, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by June 18, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders. To be notified if a class action against Sharecare, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome. Contact:Aaron Dumas, Jr. Robbins LLP5060 Shoreham Pl., Ste. 300San Diego, CA 92122adumas@robbinsllp.com(800) 350-6003www.robbinsllp.comhttps://www.facebook.com/RobbinsLLP/https://www.linkedin.com/company/robbins-llp/ A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5239e30f-03d1-425f-9bc8-45a1b26cba78 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Sharecare, Inc. Stockholders Should Contact Robbins LLP Regarding the Pending Lead Plaintiff Deadline in the SHCR Securities Class Action By: Robbins LLP via GlobeNewswire May 07, 2024 at 15:28 PM EDT SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Sharecare, Inc. (NASDAQ: SHCR) securities between May 10, 2023 and March 28, 2024. Sharecare developed an interactive health and wellness platform to help people, patients, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating the Allegations that Sharecare, Inc. (SHCR) had Material Weaknesses in Internal Control Over Financial Reporting According to the complaint, during the class period defendants failed to disclose to investors that Sharecare lacked adequate internal controls. On March 29, 2024, Sharecare filed with the SEC its Annual Report on Form 10-K for the year ended December 31, 2023, sharing that its Chief Executive Officer and Chief Financial Officer determined that the Company's disclosure controls and procedures were ineffective as of December 31, 2023, due to material weaknesses in the Company's internal control over financial reporting. On this news, the price of Sharecare stock fell by $0.2171, or 28.28%, to close at $0.5504 on April 1, 2024, on unusually heavy trading volume, damaging investors. What Now: You may be eligible to participate in the class action against Sharecare, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by June 18, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders. To be notified if a class action against Sharecare, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome. Contact:Aaron Dumas, Jr. Robbins LLP5060 Shoreham Pl., Ste. 300San Diego, CA 92122adumas@robbinsllp.com(800) 350-6003www.robbinsllp.comhttps://www.facebook.com/RobbinsLLP/https://www.linkedin.com/company/robbins-llp/ A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5239e30f-03d1-425f-9bc8-45a1b26cba78
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Sharecare, Inc. (NASDAQ: SHCR) securities between May 10, 2023 and March 28, 2024. Sharecare developed an interactive health and wellness platform to help people, patients, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating the Allegations that Sharecare, Inc. (SHCR) had Material Weaknesses in Internal Control Over Financial Reporting According to the complaint, during the class period defendants failed to disclose to investors that Sharecare lacked adequate internal controls. On March 29, 2024, Sharecare filed with the SEC its Annual Report on Form 10-K for the year ended December 31, 2023, sharing that its Chief Executive Officer and Chief Financial Officer determined that the Company's disclosure controls and procedures were ineffective as of December 31, 2023, due to material weaknesses in the Company's internal control over financial reporting. On this news, the price of Sharecare stock fell by $0.2171, or 28.28%, to close at $0.5504 on April 1, 2024, on unusually heavy trading volume, damaging investors. What Now: You may be eligible to participate in the class action against Sharecare, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by June 18, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders. To be notified if a class action against Sharecare, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome. Contact:Aaron Dumas, Jr. Robbins LLP5060 Shoreham Pl., Ste. 300San Diego, CA 92122adumas@robbinsllp.com(800) 350-6003www.robbinsllp.comhttps://www.facebook.com/RobbinsLLP/https://www.linkedin.com/company/robbins-llp/ A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5239e30f-03d1-425f-9bc8-45a1b26cba78